The Best. First. Anti-EGFR before anti-VEGF, in the first-line treatment of RAS wild-type metastatic colorectal cancer: from bench to bedside
Crossref DOI link: https://doi.org/10.1007/s00280-016-3032-8
Published Online: 2016-04-18
Published Print: 2016-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Zaniboni, A.
Formica, V.
Text and Data Mining valid from 2016-04-18